Cargando…
Effect of sodium butyrate regulating IRAK1 (interleukin-1 receptor-associated kinase 1) on visceral hypersensitivity in irritable bowel syndrome and its mechanism
The current study aimed to investigate the effects of sodium butyrate on the level of colonic protein IRAK1 (interleukin-1 receptor-associated kinase 1) in irritable bowel syndrome (IBS) models as well as revealing the relationship between IRAKI level and visceral sensitivity during the progression...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806247/ https://www.ncbi.nlm.nih.gov/pubmed/33906562 http://dx.doi.org/10.1080/21655979.2021.1920324 |
_version_ | 1784643401537290240 |
---|---|
author | He, Yuqin Tan, Yan Zhu, Jianru Wu, Xiaofeng Huang, Zhiyong Chen, Hengsheng Yang, Min Chen, Dongfeng |
author_facet | He, Yuqin Tan, Yan Zhu, Jianru Wu, Xiaofeng Huang, Zhiyong Chen, Hengsheng Yang, Min Chen, Dongfeng |
author_sort | He, Yuqin |
collection | PubMed |
description | The current study aimed to investigate the effects of sodium butyrate on the level of colonic protein IRAK1 (interleukin-1 receptor-associated kinase 1) in irritable bowel syndrome (IBS) models as well as revealing the relationship between IRAKI level and visceral sensitivity during the progression of IBS. IBS symptoms were induced using TNBS (2,4,6-trinitrobenzene sulfonic acid) in mice and using IL-33 in HT-29 cells, which were then hanlded with sodium butyrate (100 mM for each mice and 0.05 M for HT-29 cells). The threshold of visceral pain and the expression of IRAKI in mice, and the level of IRAKI in HT-29 cells were detected. The data showed that the level of IRAK1 in IBS mice was higher than that in the control group, while the pre-treatment with sodium butyrate could solidy suppressed the level of IRAK1. Morevoer, it was found that the level of IRAK1 was negatively correlated with the pain threshold. In in vitro assays, the level of IRAK1 was firstly induced by IL-33 stimulation and then suppressed by sodium butyrate pretreatment. Collectively, the level of IRAKI showed an obvioulty positive relation with visceral hypersensitivity in IBS models, and the treatment with sodium butyrate could alleviate visceral hypersensitivity by inhibiting the expression of IRAKI. |
format | Online Article Text |
id | pubmed-8806247 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-88062472022-02-02 Effect of sodium butyrate regulating IRAK1 (interleukin-1 receptor-associated kinase 1) on visceral hypersensitivity in irritable bowel syndrome and its mechanism He, Yuqin Tan, Yan Zhu, Jianru Wu, Xiaofeng Huang, Zhiyong Chen, Hengsheng Yang, Min Chen, Dongfeng Bioengineered Research Paper The current study aimed to investigate the effects of sodium butyrate on the level of colonic protein IRAK1 (interleukin-1 receptor-associated kinase 1) in irritable bowel syndrome (IBS) models as well as revealing the relationship between IRAKI level and visceral sensitivity during the progression of IBS. IBS symptoms were induced using TNBS (2,4,6-trinitrobenzene sulfonic acid) in mice and using IL-33 in HT-29 cells, which were then hanlded with sodium butyrate (100 mM for each mice and 0.05 M for HT-29 cells). The threshold of visceral pain and the expression of IRAKI in mice, and the level of IRAKI in HT-29 cells were detected. The data showed that the level of IRAK1 in IBS mice was higher than that in the control group, while the pre-treatment with sodium butyrate could solidy suppressed the level of IRAK1. Morevoer, it was found that the level of IRAK1 was negatively correlated with the pain threshold. In in vitro assays, the level of IRAK1 was firstly induced by IL-33 stimulation and then suppressed by sodium butyrate pretreatment. Collectively, the level of IRAKI showed an obvioulty positive relation with visceral hypersensitivity in IBS models, and the treatment with sodium butyrate could alleviate visceral hypersensitivity by inhibiting the expression of IRAKI. Taylor & Francis 2021-04-27 /pmc/articles/PMC8806247/ /pubmed/33906562 http://dx.doi.org/10.1080/21655979.2021.1920324 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper He, Yuqin Tan, Yan Zhu, Jianru Wu, Xiaofeng Huang, Zhiyong Chen, Hengsheng Yang, Min Chen, Dongfeng Effect of sodium butyrate regulating IRAK1 (interleukin-1 receptor-associated kinase 1) on visceral hypersensitivity in irritable bowel syndrome and its mechanism |
title | Effect of sodium butyrate regulating IRAK1 (interleukin-1 receptor-associated kinase 1) on visceral hypersensitivity in irritable bowel syndrome and its mechanism |
title_full | Effect of sodium butyrate regulating IRAK1 (interleukin-1 receptor-associated kinase 1) on visceral hypersensitivity in irritable bowel syndrome and its mechanism |
title_fullStr | Effect of sodium butyrate regulating IRAK1 (interleukin-1 receptor-associated kinase 1) on visceral hypersensitivity in irritable bowel syndrome and its mechanism |
title_full_unstemmed | Effect of sodium butyrate regulating IRAK1 (interleukin-1 receptor-associated kinase 1) on visceral hypersensitivity in irritable bowel syndrome and its mechanism |
title_short | Effect of sodium butyrate regulating IRAK1 (interleukin-1 receptor-associated kinase 1) on visceral hypersensitivity in irritable bowel syndrome and its mechanism |
title_sort | effect of sodium butyrate regulating irak1 (interleukin-1 receptor-associated kinase 1) on visceral hypersensitivity in irritable bowel syndrome and its mechanism |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806247/ https://www.ncbi.nlm.nih.gov/pubmed/33906562 http://dx.doi.org/10.1080/21655979.2021.1920324 |
work_keys_str_mv | AT heyuqin effectofsodiumbutyrateregulatingirak1interleukin1receptorassociatedkinase1onvisceralhypersensitivityinirritablebowelsyndromeanditsmechanism AT tanyan effectofsodiumbutyrateregulatingirak1interleukin1receptorassociatedkinase1onvisceralhypersensitivityinirritablebowelsyndromeanditsmechanism AT zhujianru effectofsodiumbutyrateregulatingirak1interleukin1receptorassociatedkinase1onvisceralhypersensitivityinirritablebowelsyndromeanditsmechanism AT wuxiaofeng effectofsodiumbutyrateregulatingirak1interleukin1receptorassociatedkinase1onvisceralhypersensitivityinirritablebowelsyndromeanditsmechanism AT huangzhiyong effectofsodiumbutyrateregulatingirak1interleukin1receptorassociatedkinase1onvisceralhypersensitivityinirritablebowelsyndromeanditsmechanism AT chenhengsheng effectofsodiumbutyrateregulatingirak1interleukin1receptorassociatedkinase1onvisceralhypersensitivityinirritablebowelsyndromeanditsmechanism AT yangmin effectofsodiumbutyrateregulatingirak1interleukin1receptorassociatedkinase1onvisceralhypersensitivityinirritablebowelsyndromeanditsmechanism AT chendongfeng effectofsodiumbutyrateregulatingirak1interleukin1receptorassociatedkinase1onvisceralhypersensitivityinirritablebowelsyndromeanditsmechanism |